Funding Rounds
MinervaX

MinervaX Seed (2014, $3M)

MinervaX

Developer of prophylactic vaccine against Group B Streptococcus.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $3.10M

Raised Date: 2014-08-01

Investors